FDA recall D-0003-2026

RC Outsourcing, LLC · Class II · drug

Product

Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.

Reason for recall

Lack of assurance of sterility.

Distribution

Nationwide in the US

Key facts

Status: Terminated
Initiation date: 2025-09-22
Report date: 2025-10-15
Termination date: 2026-01-05
Voluntary/Mandated: Voluntary: Firm initiated
Location: Lowellville, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0003-2026